Company intelligence / Profile preview

Seiyaku Kasei

Osaka, Osaka, Japan

Ownership: Private
Development stage: Other

Overview

Seiyaku Kasei is a Japanese pharmaceutical company specializing in the manufacture and sale of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company provides contract manufacturing services, leveraging its expertise in organic synthesis and chemical processing to support the drug development and production needs of global pharmaceutical partners. With a focus on high-quality standards, Seiyaku Kasei operates manufacturing facilities that comply with Good Manufacturing Practice (GMP) regulations. Their business model centers on the reliable supply of essential chemical components for a wide range of therapeutic products.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Seiyaku Kasei.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seiyaku Kasei.

Explore the full profile